Μικροκυτταρικό καρκίνωμα (Greek Wikipedia)

Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer, Cancer Discovery, October 2019. - American Association for Cancer Research https://cancerdiscovery.aacrjournals.org/content/9/10/1372

annalsofoncology.org

Weiss, J. M.; Csoszi, T.; Maglakelidze, M.; Hoyer, R. J.; Beck, J. T.; Gomez, M. Domine; Lowczak, A.; Aljumaily, R. και άλλοι. (2019-10-01). «Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial» (στα αγγλικά). Annals of Oncology 30 (10): 1613–21. doi:10.1093/annonc/mdz278. ISSN 0923-7534. PMID 31504118. PMC 6857609. https://www.annalsofoncology.org/article/S0923-7534(19)60981-6/abstract.

archive.org

«Brain metastasis from prostate small-cell carcinoma: not to be neglected». Can J Neurol Sci 29 (4): 375–77. November 2002. doi:10.1017/S0317167100002250. PMID 12463494. https://archive.org/details/sim_canadian-journal-of-neurological-sciences_2002-11_29_4/page/375.
World Cancer Report 2014. World Health Organization. 2014. σελίδες Chapter 5.1. ISBN 978-9283204299.
Ettinger, DS; Aisner, J (1 October 2006). «Changing face of small-cell lung cancer: real and artifact.». Journal of Clinical Oncology 24 (28): 4526–27. doi:10.1200/jco.2006.07.3841. PMID 17008688. https://archive.org/details/sim_journal-of-clinical-oncology_2006-10-01_24_28/page/4526.

asbestos.com

The Mesothelioma Center | https://www.asbestos.com/mesothelioma/small-cell/

asco.org

meetinglibrary.asco.org

Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial. | https://meetinglibrary.asco.org/record/173489/abstract

atlasgeneticsoncology.org

«Lung: Translocations in Small Cell Carcinoma». atlasgeneticsoncology.org. Αρχειοθετήθηκε από το πρωτότυπο στις 30 Ιανουαρίου 2015. Ανακτήθηκε στις 30 Απριλίου 2018.

cancer.ca

[[Treatment for Small Cell Lung Cancer, Canadian Cancer Society|http://www.cancer.ca/en/cancer-information/cancer-type/lung/treatment/treatment-for-small-cell-lung-cancer/?region=nu

cancer.gov

seer.cancer.gov

SEER Cancer Stats (2016) | https://seer.cancer.gov/explorer/application.php?site=611&data_type=4&graph_type=6&compareBy=stage&chk_sex_1=1&chk_race_1=1&chk_age_range_1=1&chk_stage_101=101&advopt_precision=1&showDataFor=sex_1_and_race_1_and_age_range_1
National Cancer Institute, SEER Explorer | https://seer.cancer.gov/explorer/application.php?site=611&data_type=4&graph_type=5&compareBy=sex&series=race&chk_sex_3=3&chk_race_2=2&chk_age_range_141=141&chk_stage_106=106&advopt_precision=1&showDataFor=age_range_141_and_stage_106
the SEER Cancer Statistics Review 1975-2015 | https://seer.cancer.gov/csr/1975_2015/browse_csr.php?sectionSEL=15&pageSEL=sect_15_table.13
[2016 Cancer Stats by SEER | https://seer.cancer.gov/explorer/application.php?site=611&data_type=4&graph_type=6&compareBy=stage&chk_sex_2=2&chk_race_1=1&chk_age_range_1=1&chk_stage_104=104&advopt_precision=1&showDataFor=sex_2_and_race_1_and_age_range_1
5-Year Relative Survival (Percent) 2008–2014 by Stage at Diagnosis | https://seer.cancer.gov/csr/1975_2015/browse_csr.php?sectionSEL=15&pageSEL=sect_15_table.13#table5
«Browse the Tables and Figures – SEER Cancer Statistics Review (CSR) 1975–2015».
[SEER Database, Cancer Survival Rates | https://seer.cancer.gov/explorer/application.php?site=611&data_type=4&graph_type=5&compareBy=age_range&series=sex&chk_sex_3=3&chk_race_3=3&chk_age_range_9=9&chk_stage_106=106&advopt_precision=1&advopt_show_se=on&advopt_show_ci=on&showDataFor=race_3_and_stage_106]
[SEER Database, Cancer Survival Rates | https://seer.cancer.gov/explorer/application.php?site=611&data_type=4&graph_type=5&compareBy=age_range&series=sex&chk_sex_3=3&chk_race_8=8&chk_age_range_9=9&chk_stage_106=106&advopt_precision=1&advopt_show_se=on&advopt_show_ci=on&showDataFor=race_8_and_stage_106]
[SEER Small Cell Lung Cancer Survival Rates | https://seer.cancer.gov/explorer/application.php?site=611&data_type=4&graph_type=6&compareBy=stage&chk_sex_3=3&chk_race_1=1&chk_age_range_1=1&chk_stage_101=101&advopt_precision=1&showDataFor=sex_3_and_race_1_and_age_range_1]

cancer.org

FDA Approves Opdivo (Nivolumab) for Small Cell Lung Cancer | https://www.cancer.org/latest-news/fda-approves-opdivo-nivolumab-for-small-cell-lung-cancer.html

cancernetwork.com

«FDA Grants Priority Review to Trilaciclib to Treat Patients with SCLC». Cancer Network. Ανακτήθηκε στις 4 Δεκεμβρίου 2020.

clevelandclinic.org

my.clevelandclinic.org

Lung Cancer – Cleveland Clinic | https://my.clevelandclinic.org/health/diseases/4375-lung-cancer

curetoday.com

«FDA Approves Opdivo for Small Cell Lung Cancer Treatment». Cure Today.
Concurrent Tecentriq Adds First Survival Benefit Seen in Small Cell Lung Cancer in 20 Years | https://www.curetoday.com/articles/concurrent-tecentriq-adds-first-survival-benefit-seen-in-small-cell-lung-cancer-in-20-years Αρχειοθετήθηκε 2019-12-31 στο Wayback Machine.

dcu.ie

doras.dcu.ie

Stordal, B.; Pavlakis, N.; Davey, R. (December 2007). «A systematic review of platinum and taxane resistance from bench to clinic: an inverse relationship». Cancer Treat. Rev. 33 (8): 688–703. doi:10.1016/j.ctrv.2007.07.013. PMID 17881133. http://doras.dcu.ie/2190/1/StordalCTR2007-Paclitaxel.pdf.

doi.org

dx.doi.org

«Advanced small cell carcinoma of the uterine cervix treated by neoadjuvant chemotherapy with irinotecan and cisplatin followed by radical surgery». Rare Tumors 3 (1): 18–20. 2011. doi:10.4081/rt.2011.e6. PMID 21464879.
«Pure small cellliterature review». Case Rep Oncol 4 (1): 88–95. 2011. doi:10.1159/000324717. PMID 21475596.
Chan, Bryan A.; Coward, Jermaine I. G. (2013). «Chemotherapy advances in small-cell lung cancer». Journal of Thoracic Disease 5 (Suppl 5): S565–S578. doi:10.3978/j.issn.2072-1439.2013.07.43. ISSN 2072-1439. PMID 24163749.
Singer, Lisa; Yom, Sue S. (2015). «Consolidative radiation therapy for extensive-stage small cell lung cancer». Translational Lung Cancer Research 4 (3): 211–14. doi:10.3978/j.issn.2218-6751.2015.04.02. ISSN 2218-6751. PMID 26207205.
Shepherd FA (February 2010). «Surgery for limited stage small cell lung cancer: time to fish or cut bait». J Thorac Oncol 5 (2): 147–49. doi:10.1097/JTO.0b013e3181c8cbf5. PMID 20101141.
Pelayo Alvarez, Marta; Westeel, Virginie; Cortés-Jofré, Marcela; Bonfill Cosp, Xavier (27 November 2013). «Chemotherapy versus best supportive care for extensive small cell lung cancer». Cochrane Database of Systematic Reviews (11): CD001990. doi:10.1002/14651858.CD001990.pub3. PMID 24282143.
Horn, Leora; Mansfield, Aaron S.; Szczęsna, Aleksandra; Havel, Libor; Krzakowski, Maciej; Hochmair, Maximilian J.; Huemer, Florian; Losonczy, György και άλλοι. (6 December 2018). «First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer». New England Journal of Medicine 379 (23): 2220–29. doi:10.1056/NEJMoa1809064. PMID 30280641.
«Lambert-Eaton myasthenic syndrome: tumor versus nontumor forms». Ann. N. Y. Acad. Sci. 1132 (1): 129–34. 2008. doi:10.1196/annals.1405.030. PMID 18567862. Bibcode: 2008NYASA1132..129T.
«Friedrich Feyrter: a precise intellect in a diffuse system». Neuroendocrinology 83 (5–6): 394–404. 2006. doi:10.1159/000096050. PMID 17028417.
Tammela, Tuomas; Sage, Julien (2020). «Investigating Tumor Heterogeneity in Mouse Models». Annual Review of Cancer Biology 4: 99–119. doi:10.1146/annurev-cancerbio-030419-033413.
«Combined small-cell carcinoma of the lung with quadripartite differentiation of epithelial, neuroendocrine, skeletal muscle, and myofibroblastic type». Virchows Arch. 458 (4): 497–503. April 2011. doi:10.1007/s00428-010-1011-8. PMID 21210145.
«A combined small cell carcinoma of the lung containing three components: small cell, spindle cell and squamous cell carcinoma». Eur J Cardiothorac Surg 26 (5): 1047–49. November 2004. doi:10.1016/j.ejcts.2004.08.002. PMID 15519208.
Ismaili N (November 2011). «A rare bladder cancer – small cell carcinoma: review and update». Orphanet Journal of Rare Diseases 6 (75): 75. doi:10.1186/1750-1172-6-75. PMID 22078012.
Cicin, Irfan; Usta, Ufuk; Karagol, Hakan; Uzunoglu, Sernaz; Kocak, Zafer (2009). «Extrapulmonary small cell carcinoma localized in lymph nodes: Is it a different clinical entity?». Acta Oncologica 48 (3): 354–60. doi:10.1080/02841860802495370. PMID 18979286.
«Small-cell carcinoma of the prostate». Journal of the Royal Society of Medicine 90 (6): 340–41. June 1997. doi:10.1177/014107689709000615. PMID 9227387.
«Brain metastasis from prostate small-cell carcinoma: not to be neglected». Can J Neurol Sci 29 (4): 375–77. November 2002. doi:10.1017/S0317167100002250. PMID 12463494. https://archive.org/details/sim_canadian-journal-of-neurological-sciences_2002-11_29_4/page/375.
Leslie M (November 2011). «Mysteries of the cell. How does a cell know its size?». Science 334 (6059): 1047–48. doi:10.1126/science.334.6059.1047. PMID 22116854.
Stordal, B.; Pavlakis, N.; Davey, R. (December 2007). «A systematic review of platinum and taxane resistance from bench to clinic: an inverse relationship». Cancer Treat. Rev. 33 (8): 688–703. doi:10.1016/j.ctrv.2007.07.013. PMID 17881133. http://doras.dcu.ie/2190/1/StordalCTR2007-Paclitaxel.pdf.
Mouri, Atsuto; Yamaguchi, Ou; Miyauchi, Sachiko; Shiono, Ayako; Utsugi, Harue; Nishihara, Fuyumi; Murayama, Yoshitake; Kagamu, Hiroshi και άλλοι. (January 2019). «Combination therapy with carboplatin and paclitaxel for small cell lung cancer». Respiratory Investigation 57 (1): 34–39. doi:10.1016/j.resinv.2018.09.004. PMID 30528688.
Qin, Angel; Kalemkerian, Gregory P. (June 2018). «Treatment Options for Relapsed Small-Cell Lung Cancer: What Progress Have We Made?». Journal of Oncology Practice 14 (6): 369–70. doi:10.1200/JOP.18.00278. PMID 29894661.
Calvo, E.; Moreno, V.; Flynn, M.; Holgado, E.; Olmedo, M.E.; Lopez Criado, M.P.; Kahatt, C.; Lopez-Vilariño, J.A. και άλλοι. (October 2017). «Antitumor activity of lurbinectedin (PM01183) and doxorubicin in relapsed small-cell lung cancer: results from a phase I study». Annals of Oncology 28 (10): 2559–66. doi:10.1093/annonc/mdx357. PMID 28961837.
Farago, Anna F; Drapkin, Benjamin J; Lopez-Vilarino de Ramos, Jose Antonio; Galmarini, Carlos M; Núñez, Rafael; Kahatt, Carmen; Paz-Ares, Luis (January 2019). «ATLANTIS: a Phase III study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one prior platinum-containing line». Future Oncology 15 (3): 231–39. doi:10.2217/fon-2018-0597. PMID 30362375.
Weiss, J. M.; Csoszi, T.; Maglakelidze, M.; Hoyer, R. J.; Beck, J. T.; Gomez, M. Domine; Lowczak, A.; Aljumaily, R. και άλλοι. (2019-10-01). «Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial» (στα αγγλικά). Annals of Oncology 30 (10): 1613–21. doi:10.1093/annonc/mdz278. ISSN 0923-7534. PMID 31504118. PMC 6857609. https://www.annalsofoncology.org/article/S0923-7534(19)60981-6/abstract.
Ettinger, DS; Aisner, J (1 October 2006). «Changing face of small-cell lung cancer: real and artifact.». Journal of Clinical Oncology 24 (28): 4526–27. doi:10.1200/jco.2006.07.3841. PMID 17008688. https://archive.org/details/sim_journal-of-clinical-oncology_2006-10-01_24_28/page/4526.
Muscat, JE; Wynder, EL (6 January 1995). «Lung cancer pathology in smokers, ex-smokers and never smokers.». Cancer Letters 88 (1): 1–5. doi:10.1016/0304-3835(94)03608-l. PMID 7850764.

doi.org

Kim, S. H., Kim, M. J., Kim, Y. J., Chang, H., Kim, J. W., Lee, J. O., Lee, K. W., Kim, J. H., Bang, S. M., & Lee, J. S. (2017). Paclitaxel as third-line chemotherapy for small cell lung cancer failing both etoposide- and camptothecin-based chemotherapy. Medicine, 96(42), e8176. https://doi.org/10.1097/MD.0000000000008176

drugs.com

Drugs.com – What is the cost of Tecentriq?| https://www.drugs.com/medical-answers/cost-tecentriq-3064818/

fda.gov

FDA approves atezolizumab for extensive-stage small cell lung cancer | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm633814.htm
Commissioner, Office of the (12 Φεβρουαρίου 2021). «FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy». FDA (στα Αγγλικά). Ανακτήθηκε στις 16 Φεβρουαρίου 2021.

g1therapeutics.com

«Trilaciclib | intravenous CDK4/6 inhibitor | G1 Therapeutics, Inc». www.g1therapeutics.com. Ανακτήθηκε στις 28 Δεκεμβρίου 2020.

harvard.edu

adsabs.harvard.edu

«Lambert-Eaton myasthenic syndrome: tumor versus nontumor forms». Ann. N. Y. Acad. Sci. 1132 (1): 129–34. 2008. doi:10.1196/annals.1405.030. PMID 18567862. Bibcode: 2008NYASA1132..129T.

iarc.fr

Travis, William D, επιμ. (2004). Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart (PDF). World Health Organization Classification of Tumours. Lyon: IARC Press. ISBN 978-92-832-2418-1. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 23 Αυγούστου 2009. Ανακτήθηκε στις 27 Μαρτίου 2010.

iaslc.org

Extensive Stage SCLC survivor Montessa M. Lee was presenting during 2019 IASLC | https://www.iaslc.org/news/focus-immunotherapy-and-patient-perspective-highlight-iaslc-2019-small-cell-lung-cancer-meetin Αρχειοθετήθηκε 2019-05-01 στο Wayback Machine.]]

immuno-oncologynews.com

Immuno-Oncology News, "FDA Approves Opdivo for Certain Patients with Advanced Small Cell Lung Cancer" | https://immuno-oncologynews.com/2018/08/21/immunotherapy-opdivo-fda-approved-some-small-cell-lung-cancer-patients/

medscape.com

emedicine.medscape.com

Extrapulmonary Small Cell Carcinoma στο eMedicine

medscape.com

Medscape "Exceptional SCLC Survivors: 5-Year Median Survival", Dec 20, 2016. | https://www.medscape.com/viewarticle/873492

nih.gov

ncbi.nlm.nih.gov

«Advanced small cell carcinoma of the uterine cervix treated by neoadjuvant chemotherapy with irinotecan and cisplatin followed by radical surgery». Rare Tumors 3 (1): 18–20. 2011. doi:10.4081/rt.2011.e6. PMID 21464879.
«Pure small cellliterature review». Case Rep Oncol 4 (1): 88–95. 2011. doi:10.1159/000324717. PMID 21475596.
Chan, Bryan A.; Coward, Jermaine I. G. (2013). «Chemotherapy advances in small-cell lung cancer». Journal of Thoracic Disease 5 (Suppl 5): S565–S578. doi:10.3978/j.issn.2072-1439.2013.07.43. ISSN 2072-1439. PMID 24163749.
«Staging and clinical prognostic factors for small-cell lung cancer». Cancer J 7 (5): 437–47. 2001. PMID 11693903.
Singer, Lisa; Yom, Sue S. (2015). «Consolidative radiation therapy for extensive-stage small cell lung cancer». Translational Lung Cancer Research 4 (3): 211–14. doi:10.3978/j.issn.2218-6751.2015.04.02. ISSN 2218-6751. PMID 26207205.
Mountain CF (September 1978). «Clinical biology of small cell carcinoma: relationship to surgical therapy». Semin. Oncol. 5 (3): 272–79. PMID 211638.
Shepherd FA (February 2010). «Surgery for limited stage small cell lung cancer: time to fish or cut bait». J Thorac Oncol 5 (2): 147–49. doi:10.1097/JTO.0b013e3181c8cbf5. PMID 20101141.
Pelayo Alvarez, Marta; Westeel, Virginie; Cortés-Jofré, Marcela; Bonfill Cosp, Xavier (27 November 2013). «Chemotherapy versus best supportive care for extensive small cell lung cancer». Cochrane Database of Systematic Reviews (11): CD001990. doi:10.1002/14651858.CD001990.pub3. PMID 24282143.
Horn, Leora; Mansfield, Aaron S.; Szczęsna, Aleksandra; Havel, Libor; Krzakowski, Maciej; Hochmair, Maximilian J.; Huemer, Florian; Losonczy, György και άλλοι. (6 December 2018). «First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer». New England Journal of Medicine 379 (23): 2220–29. doi:10.1056/NEJMoa1809064. PMID 30280641.
«Lambert-Eaton myasthenic syndrome: tumor versus nontumor forms». Ann. N. Y. Acad. Sci. 1132 (1): 129–34. 2008. doi:10.1196/annals.1405.030. PMID 18567862. Bibcode: 2008NYASA1132..129T.
«Friedrich Feyrter: a precise intellect in a diffuse system». Neuroendocrinology 83 (5–6): 394–404. 2006. doi:10.1159/000096050. PMID 17028417.
«Combined small-cell carcinoma of the lung with quadripartite differentiation of epithelial, neuroendocrine, skeletal muscle, and myofibroblastic type». Virchows Arch. 458 (4): 497–503. April 2011. doi:10.1007/s00428-010-1011-8. PMID 21210145.
«A combined small cell carcinoma of the lung containing three components: small cell, spindle cell and squamous cell carcinoma». Eur J Cardiothorac Surg 26 (5): 1047–49. November 2004. doi:10.1016/j.ejcts.2004.08.002. PMID 15519208.
Ismaili N (November 2011). «A rare bladder cancer – small cell carcinoma: review and update». Orphanet Journal of Rare Diseases 6 (75): 75. doi:10.1186/1750-1172-6-75. PMID 22078012.
Cicin, Irfan; Usta, Ufuk; Karagol, Hakan; Uzunoglu, Sernaz; Kocak, Zafer (2009). «Extrapulmonary small cell carcinoma localized in lymph nodes: Is it a different clinical entity?». Acta Oncologica 48 (3): 354–60. doi:10.1080/02841860802495370. PMID 18979286.
«Small-cell carcinoma of the prostate». Journal of the Royal Society of Medicine 90 (6): 340–41. June 1997. doi:10.1177/014107689709000615. PMID 9227387.
«Brain metastasis from prostate small-cell carcinoma: not to be neglected». Can J Neurol Sci 29 (4): 375–77. November 2002. doi:10.1017/S0317167100002250. PMID 12463494. https://archive.org/details/sim_canadian-journal-of-neurological-sciences_2002-11_29_4/page/375.
Leslie M (November 2011). «Mysteries of the cell. How does a cell know its size?». Science 334 (6059): 1047–48. doi:10.1126/science.334.6059.1047. PMID 22116854.
Stordal, B.; Pavlakis, N.; Davey, R. (December 2007). «A systematic review of platinum and taxane resistance from bench to clinic: an inverse relationship». Cancer Treat. Rev. 33 (8): 688–703. doi:10.1016/j.ctrv.2007.07.013. PMID 17881133. http://doras.dcu.ie/2190/1/StordalCTR2007-Paclitaxel.pdf.
Mouri, Atsuto; Yamaguchi, Ou; Miyauchi, Sachiko; Shiono, Ayako; Utsugi, Harue; Nishihara, Fuyumi; Murayama, Yoshitake; Kagamu, Hiroshi και άλλοι. (January 2019). «Combination therapy with carboplatin and paclitaxel for small cell lung cancer». Respiratory Investigation 57 (1): 34–39. doi:10.1016/j.resinv.2018.09.004. PMID 30528688.
Qin, Angel; Kalemkerian, Gregory P. (June 2018). «Treatment Options for Relapsed Small-Cell Lung Cancer: What Progress Have We Made?». Journal of Oncology Practice 14 (6): 369–70. doi:10.1200/JOP.18.00278. PMID 29894661.
Calvo, E.; Moreno, V.; Flynn, M.; Holgado, E.; Olmedo, M.E.; Lopez Criado, M.P.; Kahatt, C.; Lopez-Vilariño, J.A. και άλλοι. (October 2017). «Antitumor activity of lurbinectedin (PM01183) and doxorubicin in relapsed small-cell lung cancer: results from a phase I study». Annals of Oncology 28 (10): 2559–66. doi:10.1093/annonc/mdx357. PMID 28961837.
Farago, Anna F; Drapkin, Benjamin J; Lopez-Vilarino de Ramos, Jose Antonio; Galmarini, Carlos M; Núñez, Rafael; Kahatt, Carmen; Paz-Ares, Luis (January 2019). «ATLANTIS: a Phase III study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one prior platinum-containing line». Future Oncology 15 (3): 231–39. doi:10.2217/fon-2018-0597. PMID 30362375.
Weiss, J. M.; Csoszi, T.; Maglakelidze, M.; Hoyer, R. J.; Beck, J. T.; Gomez, M. Domine; Lowczak, A.; Aljumaily, R. και άλλοι. (2019-10-01). «Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial» (στα αγγλικά). Annals of Oncology 30 (10): 1613–21. doi:10.1093/annonc/mdz278. ISSN 0923-7534. PMID 31504118. PMC 6857609. https://www.annalsofoncology.org/article/S0923-7534(19)60981-6/abstract.
Ettinger, DS; Aisner, J (1 October 2006). «Changing face of small-cell lung cancer: real and artifact.». Journal of Clinical Oncology 24 (28): 4526–27. doi:10.1200/jco.2006.07.3841. PMID 17008688. https://archive.org/details/sim_journal-of-clinical-oncology_2006-10-01_24_28/page/4526.
Muscat, JE; Wynder, EL (6 January 1995). «Lung cancer pathology in smokers, ex-smokers and never smokers.». Cancer Letters 88 (1): 1–5. doi:10.1016/0304-3835(94)03608-l. PMID 7850764.

pubmedcentral.nih.gov

«Advanced small cell carcinoma of the uterine cervix treated by neoadjuvant chemotherapy with irinotecan and cisplatin followed by radical surgery». Rare Tumors 3 (1): 18–20. 2011. doi:10.4081/rt.2011.e6. PMID 21464879.
«Pure small cellliterature review». Case Rep Oncol 4 (1): 88–95. 2011. doi:10.1159/000324717. PMID 21475596.
Chan, Bryan A.; Coward, Jermaine I. G. (2013). «Chemotherapy advances in small-cell lung cancer». Journal of Thoracic Disease 5 (Suppl 5): S565–S578. doi:10.3978/j.issn.2072-1439.2013.07.43. ISSN 2072-1439. PMID 24163749.
Singer, Lisa; Yom, Sue S. (2015). «Consolidative radiation therapy for extensive-stage small cell lung cancer». Translational Lung Cancer Research 4 (3): 211–14. doi:10.3978/j.issn.2218-6751.2015.04.02. ISSN 2218-6751. PMID 26207205.
Ismaili N (November 2011). «A rare bladder cancer – small cell carcinoma: review and update». Orphanet Journal of Rare Diseases 6 (75): 75. doi:10.1186/1750-1172-6-75. PMID 22078012.
«Small-cell carcinoma of the prostate». Journal of the Royal Society of Medicine 90 (6): 340–41. June 1997. doi:10.1177/014107689709000615. PMID 9227387.
Calvo, E.; Moreno, V.; Flynn, M.; Holgado, E.; Olmedo, M.E.; Lopez Criado, M.P.; Kahatt, C.; Lopez-Vilariño, J.A. και άλλοι. (October 2017). «Antitumor activity of lurbinectedin (PM01183) and doxorubicin in relapsed small-cell lung cancer: results from a phase I study». Annals of Oncology 28 (10): 2559–66. doi:10.1093/annonc/mdx357. PMID 28961837.
Farago, Anna F; Drapkin, Benjamin J; Lopez-Vilarino de Ramos, Jose Antonio; Galmarini, Carlos M; Núñez, Rafael; Kahatt, Carmen; Paz-Ares, Luis (January 2019). «ATLANTIS: a Phase III study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one prior platinum-containing line». Future Oncology 15 (3): 231–39. doi:10.2217/fon-2018-0597. PMID 30362375.
Weiss, J. M.; Csoszi, T.; Maglakelidze, M.; Hoyer, R. J.; Beck, J. T.; Gomez, M. Domine; Lowczak, A.; Aljumaily, R. και άλλοι. (2019-10-01). «Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial» (στα αγγλικά). Annals of Oncology 30 (10): 1613–21. doi:10.1093/annonc/mdz278. ISSN 0923-7534. PMID 31504118. PMC 6857609. https://www.annalsofoncology.org/article/S0923-7534(19)60981-6/abstract.

cgap.nci.nih.gov

«Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer». Αρχειοθετήθηκε από το πρωτότυπο στις 29 Μαΐου 2016.

onclive.com

Reuters, "NICE Cites Cost in Deciding Against Atezolizumab for Frontline Advanced Small Cell Lung Cancer", Jan 6, 2020 https://www.onclive.com/web-exclusives/nice-cites-cost-in-deciding-against-atezolizumab-for-frontline-advanced-small-cell-lung-cancer Αρχειοθετήθηκε 2020-02-22 στο Wayback Machine.

oncolink.org

[https://www.oncolink.org/healthcare-professionals/nci/pqid-CDR00000629452%7C^{[νεκρός σύνδεσμος]} National Cancer Institute: Small Cell Lung Cancer Treatment

prnewswire.com

Emas, Bionical. «PharmaMar and Bionical Emas Launch Expanded Access Program for Lurbinectedin in Relapsed Small Cell Lung Cancer in the U.S.». www.prnewswire.com.

rarediseases.org

National Organization for Rare Disorders – Small Cell Lung Cancer | https://rarediseases.org/rare-diseases/small-cell-lung-cancer/

reuters.com

ca.reuters.com

Reuters, "Canadian regulator considers changes to new drug pricing plan", Feb 20, 2020. https://ca.reuters.com/article/domesticNews/idCAKBN20E2LI Αρχειοθετήθηκε 2020-11-26 στο Wayback Machine.

tecentriq-hcp.com

Tecentriq: "Updated exploratory OS analysis" | https://www.tecentriq-hcp.com/sclc/clinical-data-efficacy/study-efficacy.html

uspharmacist.com

staff, By. «FDA Grants Priority Review of Trilaciclib for Treating Small Cell Lung Cancer». www.uspharmacist.com (στα Αγγλικά). Ανακτήθηκε στις 28 Δεκεμβρίου 2020.

web.archive.org

Travis, William D, επιμ. (2004). Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart (PDF). World Health Organization Classification of Tumours. Lyon: IARC Press. ISBN 978-92-832-2418-1. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 23 Αυγούστου 2009. Ανακτήθηκε στις 27 Μαρτίου 2010.
Concurrent Tecentriq Adds First Survival Benefit Seen in Small Cell Lung Cancer in 20 Years | https://www.curetoday.com/articles/concurrent-tecentriq-adds-first-survival-benefit-seen-in-small-cell-lung-cancer-in-20-years Αρχειοθετήθηκε 2019-12-31 στο Wayback Machine.
Reuters, "Canadian regulator considers changes to new drug pricing plan", Feb 20, 2020. https://ca.reuters.com/article/domesticNews/idCAKBN20E2LI Αρχειοθετήθηκε 2020-11-26 στο Wayback Machine.
Reuters, "NICE Cites Cost in Deciding Against Atezolizumab for Frontline Advanced Small Cell Lung Cancer", Jan 6, 2020 https://www.onclive.com/web-exclusives/nice-cites-cost-in-deciding-against-atezolizumab-for-frontline-advanced-small-cell-lung-cancer Αρχειοθετήθηκε 2020-02-22 στο Wayback Machine.
Extensive Stage SCLC survivor Montessa M. Lee was presenting during 2019 IASLC | https://www.iaslc.org/news/focus-immunotherapy-and-patient-perspective-highlight-iaslc-2019-small-cell-lung-cancer-meetin Αρχειοθετήθηκε 2019-05-01 στο Wayback Machine.]]

wikimedia.org

commons.wikimedia.org

Smokers defined as current or former smoker of more than 1 year of duration. See image page in Commons for percentages in numbers. Reference:

wikiwix.com

archive.wikiwix.com

«Lung: Translocations in Small Cell Carcinoma». atlasgeneticsoncology.org. Αρχειοθετήθηκε από το πρωτότυπο στις 30 Ιανουαρίου 2015. Ανακτήθηκε στις 30 Απριλίου 2018.
«Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer». Αρχειοθετήθηκε από το πρωτότυπο στις 29 Μαΐου 2016.
«Atlas of Genetics and Cytogenetics in Oncology and Haematology». atlasgeneticsoncology.org. Αρχειοθετήθηκε από το πρωτότυπο στις 23 Φεβρουαρίου 2011.

worldcat.org

Chan, Bryan A.; Coward, Jermaine I. G. (2013). «Chemotherapy advances in small-cell lung cancer». Journal of Thoracic Disease 5 (Suppl 5): S565–S578. doi:10.3978/j.issn.2072-1439.2013.07.43. ISSN 2072-1439. PMID 24163749.
Singer, Lisa; Yom, Sue S. (2015). «Consolidative radiation therapy for extensive-stage small cell lung cancer». Translational Lung Cancer Research 4 (3): 211–14. doi:10.3978/j.issn.2218-6751.2015.04.02. ISSN 2218-6751. PMID 26207205.
Weiss, J. M.; Csoszi, T.; Maglakelidze, M.; Hoyer, R. J.; Beck, J. T.; Gomez, M. Domine; Lowczak, A.; Aljumaily, R. και άλλοι. (2019-10-01). «Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial» (στα αγγλικά). Annals of Oncology 30 (10): 1613–21. doi:10.1093/annonc/mdz278. ISSN 0923-7534. PMID 31504118. PMC 6857609. https://www.annalsofoncology.org/article/S0923-7534(19)60981-6/abstract.